The global opioid use disorder market was valued at USD 2.20 Billion in 2023 and is projected to grow at a CAGR of 10.00% over the forecast period of 2024-2032 owing to the increasing opioid use and the launch of government policies to control the crisis in the U.S.
Base Year
Historical Year
Forecast Year
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Opioid use disorder is a chronic illness combined with compulsive, prolonged, and repeated self-administration of opioids. There are two kinds of patients in opioid use disorder: patients addicted to non-medical opioids and patients addicted to medical opioids. The opioid use disorder market is segmented based on drugs:
Market Breakup Drugs:
Market Breakup by Region:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global opioid use disorder market is being driven by the rising cases of opioid addiction. The industry is further driven by factors like the commercialization of a few drugs that are approved for the treatment and genericized across various markets. Buprenorphine-Sublocade is anticipated to be the fastest-growing industry as it directs the restrictions of existing treatment by replacing daily oral medications with an injectable, thus, making diversion and abuse difficult and improving quality of life. North America is the largest market due to the epidemic of opioids in the U.S. and Canada, and the introduction of policies by the government to control the crisis. The U.S. government in January 2018 launched an awareness advertising campaign to resist opioid addiction.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global opioid use disorder market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global opioid use disorder market attained a value of USD 2.20 Billion in 2023.
In the forecast period 0f 2024-2032, the market is projected to grow at a CAGR of 10.00%.
The major drivers of the market include commercialisation of a few drugs, introduction of policies by the government, and improving quality of life are expected to aid the industry growth.
Rising cases of opioid addiction and growing dependency on drugs are expected to boost the market growth.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the major regions in the market, with North America accounting for the largest share in the market.
The major drugs of the product are buprenorphine, methadone, and naltrexone. Buprenorphine is further divided into bunavail, sublocade, suboxone, and zubsolv, among others.
The major players in the market are Indivior PLC, BioDelivery Sciences International, Inc., Alkermes plc, Titan Pharmaceuticals, Inc., Camurus AB., Others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share